Aeglea BioTherapeutics Inc. (AGLE) Rose 5.25% or 0.38 To Price $7.62 On Monday


Aeglea BioTherapeutics Inc. (AGLE) rose 5.25% or 0.38 to $7.62. It is near to 160000 shares traded, which is 201.12% compare to the average total volume 79554. The market cap of AGLE is $126.83 million. The year to date change is 34.57%. The 52 week price range is from $2.81 to $8.14. Price of AGLE have changed 13.48% during last week. It have changed 15.47% over last month, 52.74% over last 3 months, 75.52% over last 6 months and 18.88% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 6.11. It is -19.82% below current price. The 200-day Moving Averages for AGLE is 4.74. It is -37.80% below current price. The 52-week High is 8.14. It is 6.82% from the current price. The 52-week Low is 2.81. It is -63.12% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 0.32 on 2018-02-15. Short % to float is 0.17%. There are some statistics of AGLE. It is has market cap $126.83 million. The share outstanding is 16.64 million. The average volume is 79554. The revenue is 4.97M. The percent of top 15 Institution holding is 34.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -42.42%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -39.58%.


Tags:

Share this post